RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

57 hedge funds and large institutions have $129M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+2
Holders Change %
+3.64%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
8
Increased
30
Reduced
9
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
51
Bank of America
North Carolina
$32K -$3.53K -112 -10%
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$29.3K +$26.6K +840 +988%
Canada Life
53
Canada Life
Manitoba, Canada
$28K +$28K +900 New
AIP
54
Ameritas Investment Partners
Nebraska
$24K +$9.77K +304 +69%
Barclays
55
Barclays
United Kingdom
$6K +$495 +16 +9%
Citigroup
56
Citigroup
New York
$3K -$22K -668 -88%
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$2K -$3.91K -129 -66%
ACM
58
Ativo Capital Management
Illinois
-$1.13M -50,012 Closed
Daiwa Securities Group
59
Daiwa Securities Group
Japan
-$829K -36,611 Closed
Millennium Management
60
Millennium Management
New York
-$727K -32,108 Closed
TRCT
61
Tower Research Capital (TRC)
New York
-$4K -155 Closed
Walleye Trading
62
Walleye Trading
New York
-$2 -100 Closed
MAM
63
Meeder Asset Management
Ohio
-$1K -30 Closed